Digestive and Liver Disease

Papers
(The median citation count of Digestive and Liver Disease is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Understanding short bowel syndrome: Current status and future perspectives79
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO76
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration73
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis66
Diagnosing chronic atrophic gastritis by gastroscopy using artificial intelligence61
COVID 19 and liver: An A–Z literature review60
Systemic inflammation as fuel for acute liver injury in COVID-1959
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial59
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis55
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine53
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver51
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies50
Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national survey48
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map46
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis45
Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases44
Foreign body and caustic ingestions in children: A clinical practice guideline43
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review42
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging40
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD40
Intestinal ischemia in the COVID-19 era40
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey40
COVID-19 and intestinal inflammation: Role of fecal calprotectin38
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function37
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population36
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease35
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment34
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)33
Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGH33
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data32
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection32
Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein31
Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway30
Therapeutic options for coeliac disease: What else beyond gluten-free diet?28
Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy28
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis27
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey27
COVID-19 in IBD: The experience of a single tertiary IBD center27
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-1926
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis25
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis25
Esophageal perforation in eosinophilic esophagitis: A systematic review on clinical presentation, management and outcomes25
Update on gastroenteropancreatic neuroendocrine tumors25
Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis25
Endoscopic ultrasound-guided vs ERCP-guided biliary drainage for malignant biliary obstruction: A up-to-date meta-analysis and systematic review24
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)24
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila23
Gastritis: The clinico-pathological spectrum23
L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet23
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis23
Splanchnic vein thrombosis in COVID-19: A review of literature22
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring22
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis22
Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B22
Latest insights into the hot question of proton pump inhibitor safety – a narrative review22
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population21
The impact of reader fatigue on the accuracy of capsule endoscopy interpretation21
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms21
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients21
High rate of re-bleeding after application of Hemospray for upper and lower gastrointestinal bleeds20
The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up20
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)20
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population20
Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group19
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program19
Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study19
MAFLD vs NAFLD: Where are we?19
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology19
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey18
Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario18
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial18
A negative fallout of COVID-19 lockdown in Italy: Life-threatening delay in the diagnosis of celiac disease18
Seronegative autoimmune atrophic gastritis is more common in elderly patients18
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation18
Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine18
Stylet slow-pull vs. standard suction technique for endoscopic ultrasound-guided fine needle biopsy in pancreatic solid lesions using 20 Gauge Procore™ needle: A multicenter randomized trial18
Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus–related diseases17
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs17
“Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial”17
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis17
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic17
Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region16
Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages16
Painless chronic pancreatitis16
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration16
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study16
Vaccinations and inflammatory bowel disease – a systematic review16
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis16
Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)16
Female reproductive health and inflammatory bowel disease: A practice-based review16
Italian guidelines for the management of irritable bowel syndrome16
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group16
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study16
Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms16
Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma16
Time course and risk factors of evolution from potential to overt autoimmune gastritis15
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist15
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group15
NAFLD, MAFLD and DAFLD15
LncRNA miR503HG inhibits epithelial-mesenchymal transition and angiogenesis in hepatocellular carcinoma by enhancing PDCD4 via regulation of miR-15b15
Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis15
Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients15
Onset of ulcerative colitis during SARS-CoV-2 infection15
Covid-19 and alcohol associated liver disease15
Long term results of liver transplantation for alpha-1 antitrypsin deficiency15
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease15
Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease15
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review15
IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway15
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis15
Intelligent detection endoscopic assistant: An artificial intelligence-based system for monitoring blind spots during esophagogastroduodenoscopy in real-time15
Treatment of primary sclerosing cholangitis15
Esophageal reflux hypersensitivity: Non-GERD or still GERD?15
Hepatitis B reactivation and immune check point inhibitors14
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade14
Assessment of biopsy proven liver fibrosis by two-dimensional shear wave elastography in patients with primary biliary cholangitis14
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance14
Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways14
Histopathology of inflammatory bowel disease — Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pa14
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort14
Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model14
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis14
Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis14
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group14
Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality14
Clinical management and patient outcomes of acute lower gastrointestinal bleeding. A multicenter, prospective, cohort study14
Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus14
Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?14
TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection13
Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort.13
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group13
Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease13
Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials13
Will the COVID-19 pandemic affect HCV disease burden?13
Italian association for the study of the liver position statement on SARS-CoV2 vaccination13
Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators13
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis13
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis13
Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease13
Clinical application of carbon nanoparticles in lymphatic mapping during colorectal cancer surgeries: A systematic review and meta-analysis13
COVID-19-related thrombotic microangiopathy in a cirrhotic patient13
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab12
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M212
FAPI PET/CT research progress in digestive system tumours12
A deep learning method to assist with chronic atrophic gastritis diagnosis using white light images12
Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO)12
The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients12
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry12
SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic12
The application of artificial intelligence in hepatology: A systematic review12
High mutation prevalence of precore and basal core promoter in pregnant women who underwent spontaneous HBeAg seroconversion within one year postpartum12
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease12
Current treatment options of refractory ascites in liver cirrhosis – A systematic review and meta-analysis12
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis12
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study12
Vaccinations in patients with inflammatory bowel disease12
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study12
Hepatic epithelioid hemangioendothelioma: An international multicenter study12
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines12
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease11
Low frequency of COVID-19 in inflammatory bowel diseases11
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial11
Contribution of high body mass index and alcohol use to liver cancer-related mortality: A study based on 195 countries or territories11
Higher rate of en bloc resection with underwater than conventional endoscopic mucosal resection: A meta-analysis11
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment11
Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis11
Prevalence and diagnostic outcomes of children with duodenal lesions and negative celiac serology11
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel11
Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study11
Spontaneous portosystemic shunts in cirrhosis: Detection, implications, and clinical associations11
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure11
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic11
High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina11
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study11
Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies11
Two decades of pediatric celiac disease in a tertiary referral center: What has changed?11
Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers–a role for MMP-9/TIMP-111
A retrospective study on efficacy of the ERAS protocol in patients undergoing surgery for Crohn disease: A propensity score analysis11
Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis11
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak11
Post COVID-19 cholangiopathy – A deep dive11
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed11
Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis11
Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease10
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFR10
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)10
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts10
Hospital readmission of patients with hepatic encephalopathy: Is the introduction of the formal caregiver useful in care management?10
Trends in cirrhosis hospitalizations during the COVID-19 pandemic10
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial10
Assessment of public perceptions and concerns of celiac disease: A Twitter-based sentiment analysis study10
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study10
Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769–5p10
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy10
Medical therapy versus surgery in moderate-to-severe ulcerative colitis10
Magnetic resonance imaging assessment of body composition parameters in Crohn's disease10
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis10
A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation10
Endoscopic snare papillectomy for adenoma of the ampulla of vater: Long-term results in 135 consecutive patients10
HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro10
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers10
Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme10
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank10
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study10
Early microscopic findings in preclinical inflammatory bowel disease10
Genetic and non-genetic risk factors for early-onset pancreatic cancer10
Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis10
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices9
Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation9
Older patients with eosinophilic esophagitis have high treatment response to topical steroids9
Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival9
Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection9
Clinical impact of videocapsule and double balloon enteroscopy on small bowel bleeding: Results from a large monocentric cohort in the last 19 years9
What gastroenterologists should know about direct oral anticoagulants9
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily9
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus9
Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease9
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function9
Gastrointestinal endoscopy in children and adults: How do they differ?9
Clinical features and psychological impact of celiac disease at diagnosis9
Gastric microbiota composition in patients with corpus atrophic gastritis9
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors9
The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis9
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation9
c-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: A new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition9
Safety in digestive endoscopy procedures in the covid era recommendations in progres of the italian society of digestive endoscopy9
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)9
Laryngeal signs and pH-multichannel intraluminal impedance in infants and children: The missing ring9
Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience9
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis9
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin9
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children9
Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis9
Complete response to the combination of sintilimab and IBI305 for a patient with HBV-associated hepatocellular carcinoma with multiple lung metastasis9
Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation9
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease9
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry8
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?8
Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324–3p/GLYATL1 axis8
Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?8
LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathway8
Collagenous gastritis: Epidemiology and clinical associations8
Double-headed small-bowel capsule endoscopy: Real-world experience from a multi-centre British study8
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients8
WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability8
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-198
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement8
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease8
Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement8
HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade8
0.053400039672852